Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 314-320

  Jeyarasasingam, Gayathri ^a,b   Yeluashvili, Michael ^a   Quik, Maryka ^a  

^a PARKINSON S INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; N(G) METHYLARGININE; NICOTINIC ACID; NICOTINIC RECEPTOR; NITRIC OXIDE; PARAOXON; PARATHION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DEGENERATION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; MUSCLE ATROPHY; MUSCLE CELL; MYASTHENIA; MYOPATHY; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYNAPTIC TRANSMISSION;

ANIMALS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLES; MUSCULAR DISEASES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARAOXON; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0033803119     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors
2. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice
3. Synaptic signaling by nitric oxide
4. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains
5. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne's muscular dystrophy
6. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
7. Twitch potentiation by organophosphate anticholinesterases in rat phrenic nerve diaphragm preparations
8. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic dopaminergic neurons: Modulation by inhibition of nitric oxide synthesis
9. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase
10. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
11. Calcium permeability of the nicotinic acetylcholine receptor: The single-channel calcium influx is significant
12. Mechanisms of activation of muscle nicotinic acetylcholine and the time course of endplate currents
13. Involvement of nitric oxide in nicotinic receptor-mediated myopathy
14. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel
15. Chronic inhibition of cholinesterase as a cause of myopathy
16. Nitric oxide signaling in the central nervous system
17. Differential action of 7-nitro indazole on rat brain nitric oxide synthase
18. Chloryrifos, parathion and their oxons bind to and desensitize a nicotinic acetylcholine receptor: Relevance to their toxicities
19. Ischaemia-reperfusion injury in mouse skeletal muscle is reduced by N-omega-nitro-L-arginine methyl ester and dexamethasone
20. Nitric oxide in skeletal muscle
21. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships
22. Ultrastructural changes at the motor end-plate produced by an irreversible cholinesterase inhibitor
23. Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor
24. Agonist-induced myopathy at the neuromuscular junction is mediated by calcium
25. Calcium-mediated myopathy at neuromuscular junctions of normal and dystrophic muscle
26. Excitatory amino acids as a final common pathway for neurologic disorders
27. Neuronal calcium homeostasis
28. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
29. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor
30. Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimulation in vivo
31. Involvement of nitric oxide system in experimental muscle crush injury
32. The stress of Gulf War syndrome
33. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice
34. Neuronal nitric-oxide synthase-m, an alternatively spliced isoform expressed in differentiated skeletal muscle
35. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells
36. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine
37. Differential effects of physostigmine and organophosphates on nicotinic receptors in neuronal cells of different species
38. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart
39. Paraoxon-induced myopathy: Muscle specificity and acetylcholine involvement
40. Relationship between acetylcholinesterase inhibition and the development of a myopathy